XML 18 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Shareholders' Equity - USD ($)
Total
Common stock issued for licensing rights
Common Stock
Common Stock
Common stock issued for licensing rights
Additional Paid-in Capital
Additional Paid-in Capital
Common stock issued for licensing rights
Accumulated Deficit
Beginning Balance at Dec. 31, 2012 $ 23,068,014   $ 5,150   $ 66,231,694   $ (43,168,830)
Beginning balance (in shares) at Dec. 31, 2012     51,500,996        
Exercise of warrants 6,176,336   $ 344   6,175,992    
Exercise of warrants (in shares)     3,441,551        
Cashless exercise of warrants     $ 3   (3)    
Cashless exercise of warrants (in shares)     31,155        
Exercise of stock options $ 324,517   $ 53   324,464    
Exercise of stock options (in shares) 829,702   528,702        
Cashless exercise of stock options     $ 15   (15)    
Cashless exercise of stock options (in shares)     149,385        
Stock based compensation $ 724,215   $ 3   724,212    
Common stock issued for license rights   $ 75,014   $ 17   $ 74,997  
Common stock issued for license rights (in shares)       28,300      
Common stock issued through controlled equity offering 4,906,061   $ 169   4,905,892    
Common stock issued through controlled equity offering (in shares)     1,862,142        
Net loss (8,800,563)           (8,800,563)
Ending Balance at Dec. 31, 2013 26,473,594   $ 5,754   $ 78,437,233   (51,969,393)
Ending balance (in shares) at Dec. 31, 2013     57,542,231        
Exercise of warrants 0   $ 0      
Exercise of warrants (in shares)     0        
Cashless exercise of warrants     $ 0      
Cashless exercise of warrants (in shares)     0        
Exercise of stock options $ 1,045,000   $ 95   $ 1,044,905    
Exercise of stock options (in shares) 624,047   950,000        
Cashless exercise of stock options     $ 3   (3)    
Cashless exercise of stock options (in shares)     28,473        
Stock based compensation $ 654,260       654,260    
Common stock issued through controlled equity offering 4,496,322   $ 508   4,495,814    
Common stock issued through controlled equity offering (in shares)     5,084,119        
Net loss (9,377,533)           (9,377,533)
Ending Balance at Dec. 31, 2014 23,291,643   $ 6,360   84,632,209   (61,346,926)
Ending balance (in shares) at Dec. 31, 2014     63,604,823        
Exercise of stock options $ 6,750   $ 3   6,747    
Exercise of stock options (in shares) 50,000   25,000        
Cashless exercise of stock options     $ 1   (1)    
Cashless exercise of stock options (in shares)     10,326        
Stock based compensation $ 916,028   $ 2   916,026    
Stock based compensation (in shares)     20,000        
Common stock issued through controlled equity offering 10,296,689   $ 2,665   10,294,024    
Common stock issued through controlled equity offering (in shares)     26,650,000        
Net loss (12,790,814)           (12,790,814)
Ending Balance at Dec. 31, 2015 $ 21,720,296   $ 9,031   $ 95,849,005   $ (74,137,740)
Ending balance (in shares) at Dec. 31, 2015     90,310,149